Calcium Bone Density Meta-analysis: What the Evidence Says

Quick Answer

Calcium Bone Density Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• FHA is a state of estrogen deficiency leading to detrimental skeletal effects, including insufficient peak bone mass accrual if onset is in adolescent/early adult life, low BMD, impaired bone microarchitecture, and resultant increased fracture risk. [Efthymiadis Agathoklis (2026); evidence level 1]
• Indeed, fracture risk is 2-7 times higher than in age and sex-matched healthy women. [Efthymiadis Agathoklis (2026); evidence level 1]
• Osteoporosis is a prevalent chronic disease characterized by systemic deterioration in bone mass and microstructures, leading to an increased risk of fractures. [Pang Yuqi (2026); evidence level 1]
• As global population ages, the impairment of physical function, comorbidity, and mortality associated with osteoporosis is expected to rise, thereby bringing a huge medical and social burden. [Pang Yuqi (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For calcium bone density meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Efthymiadis Agathoklis (2026). Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials. DOI: 10.1210/clinem/dgag005. PMCID: PMC13099214. PMID: 41505334. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13099214/
• Pang Yuqi (2026). Association between dietary fiber intake and bone mineral density: a systematic review and meta-analysis of observational studies. DOI: 10.1007/s00394-025-03866-9. PMCID: PMC12935702. PMID: 41739242. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12935702/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.